High urgency

Pinnacle Treatment Centers Launches Telehealth Methadone Prescriptions Amid Landmark Rule Change - Behavioral Health Business

Detected July 6, 2026 · in Telehealth Cross-State Licensing

Pinnacle Treatment Centers launches telehealth methadone prescriptions following a landmark rule change, likely the final rule allowing audio-video telehealth for buprenorphine and methadone initiation without an in-person exam. This signals regulatory acceptance of telehealth for controlled substance prescribing, impacting cross-state licensing and compliance requirements.

Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon rule publication; likely within 30 days for full compliance.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

The DEA's final rule (expected to be published soon) allows telehealth prescribing of buprenorphine and methadone for OUD without an initial in-person visit, under specific conditions. This changes the Ryan Haight Act requirements and may affect state licensure compacts like IMLC and PSYPACT.

Who it affects

Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers

What you must do

Review and update telehealth prescribing protocols to align with the new rule, ensure compliance with state-specific controlled substance laws, and verify cross-state licensure requirements for prescribing controlled substances via telehealth.

Deadline

Immediately upon rule publication; likely within 30 days for full compliance.

Source: https://news.google.com/rss/articles/CBMiywFBVV95cUxPRmFyWTJPRTBFVklHRThfOFJKaklPWlpxRElkUHduWTFWVWlJTjJ2QUg0Q2puUG1iQ1Z3N0g1am1NbURRaUVTdmFuLWgyR3ItblFXV2V5VHhGT3ljQ1JYLXhvbVhGLUhQZHRuUWlmNHFYS3JCcGJrcmtTbGc3VVN1Tm1TU01NbWJULTJ5UUF5SzlibENlamxkc0NIZDZ3bXZDLWVMNFhIQklyLU1ndk9KRENtdEI5T1pOczd2c1dhNnlKMDgtWUJVWlM5RQ?oc=5

Never miss a change like this again

Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Telehealth Cross-State Licensing